Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU

Biochem Biophys Res Commun. 2012 Feb 24;418(4):616-21. doi: 10.1016/j.bbrc.2012.01.049. Epub 2012 Jan 28.

Abstract

In this study, we investigate an anti-mitotic potential of the novel synthetic coumarin-based compound, 7-diethylamino-3(2'-benzoxazolyl)-coumarin, in 5-fluorouracil-resistant human gastric cancer cell line SNU-620-5FU and its parental cell SNU-620. It exerts the anti-proliferative effects with similar potencies against both cancer cells, which is mediated by destabilization of microtubules and subsequent mitotic arrest. Furthermore, this compound enhances caspase-dependent apoptotic cell death via decreased expression of anti-apoptotic genes. Taken together, our data strongly support anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin against drug-resistant cancer cells which will prompt us to further develop as a novel microtubule inhibitor for drug-resistant cancer chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Antimitotic Agents / pharmacology*
  • Apoptosis / drug effects
  • Benzoxazoles / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Coumarins / pharmacology*
  • Drug Resistance, Neoplasm*
  • Fluorouracil / pharmacology*
  • Humans
  • Stomach Neoplasms / drug therapy*
  • Tubulin Modulators / pharmacology

Substances

  • 7-diethylamino-3(2'-benzoxazolyl)coumarin
  • Antimetabolites, Antineoplastic
  • Antimitotic Agents
  • Benzoxazoles
  • Coumarins
  • Tubulin Modulators
  • Fluorouracil